The rise of nanometers

The two parties have entered into negotiations on the details of cooperation.

Lin Baijie gave a large cooperation package, including pure water supply, sewage and waste treatment, industrial software and information technology services.

As a large-scale special glass manufacturing industry, Shandong Pharmaceutical Glass has a lot of demand for pure water. According to glass manufacturing technology, on average, about 0.3 tons of pure water are consumed for every ton of glass produced.

The water supplied from ordinary tap water has too many impurities. Without further treatment, there is no way to use it for Shandong Pharmaceutical Glass, which produces medicinal glass products.

Hu Chengjun also had some knowledge of the water purification technology owned by Suiren Company's Blue Age.

For the same pollution treatment, Shandong Pharmaceutical Industry's annual expenditure is also not small.

The various cooperation plans provided by Suiren Company can basically save about 20 to 30% compared to Shandong Pharmaceutical Glass doing it on its own.

Unless Hu Chengjun is a fool, he will reject this cooperation plan if it is profitable. Lu Province Pharmaceuticals has no reason to refuse. It can save so many costs, and these are profits.

Industrial software and software information services can be regarded as giving Suiren company face, which is also part of the bundled sales.

Among other cooperation details, there are industry restrictions and electroplating agent restrictions. For products using silicon nano-coating, orders exported to foreign countries must be reported to Suiren Company to ensure that there are no prohibited uses.

Contract negotiations took several days before both parties finalized all the details.

December 24th.

The official website of Suiren Company disclosed a piece of cooperation information. No one noticed it at first, but in the A-share market, the stock price of Lu Province Pharmaceutical Glass hit the daily limit that day.

On the time blog.

A blog post forwarded from the A-share circle, the click-through rate and popularity skyrocketed.

The blogger named "Fourier Formula" published a stock analysis report. The blog post was titled "Analysis of Cooperation between Shandong Pharmaceutical Glass and Suiren Company."

After seeing this article, many people went to the official website of Suiren Company and the official website of Shandong Pharmaceutical Glass to search and found that there was indeed cooperation.

[I feel that Shandong Pharmaceutical Glass is about to rise sharply. I just opened 500 positions today and made a profit of three points. ]——Old Leek

[ @Lao Liec, Laoge V5. ]——Chicago Typewriter

[Suiren Company cooperates with Lu Province Pharmaceutical Glass? Or is it medicinal glass technology? Isn’t his family engaged in water affairs and recycling?] - Spicy Tofu Nao

[Judging from the disclosed cooperation announcement, the patent fee for each pharmaceutical bottle of Shandong Pharmaceutical Glass has reached 15% of the ex-factory price. How awesome is the technology?] - Stray Cat

[Comprehensive replacement of medium borosilicate glass products, pharmaceutical bottles made with new technology, water resistance is zero? Bragging, no drafts. ]——Big Mouth (professional purchasing for pharmaceutical companies)

［ @Lao Jiucai, what about Zhengchuan shares, which is also a medicinal glass? Is it worth buying?】——Wall Street Salted Fish

At first, the netizens discussing this matter were limited to people in the stock circle, but as time went by, other netizens also joined the discussion.

The next day, Luzhou Pharmaceutical Glass once again hit the daily limit, while peers such as Zhengchuan Shares saw significant declines.

In this year's economic crisis, in addition to infrastructure, real estate, building materials, etc. that benefited from the RMB 4 trillion, Shandong Pharmaceutical Glass was one of the few stocks that unexpectedly hit the daily limit.

This has aroused more people's curiosity. Since Shandong Pharmaceutical Glass is a listed company, it must disclose cooperation details. Through the securities company's software, you can see the specific cooperation details.

People who are not in this industry can only watch the excitement, but people in the industry feel incredible.

You must know that the profit of domestic medicinal glass products is very slim, usually around 3 to 6%, and they also face the risk of being held back for payment.

Giving a 15% patent fee all at once is basically giving money away.

However, Shandong Pharmaceutical Glass did not explain much. It is currently working hard to transform the production line, transforming an ordinary low borosilicate pharmaceutical bottle production line into a silicon nanomedicine bottle production line.

With the cooperation of Snail Industry, the transformation of the first production line was quickly completed. This is a production line covering all processes.

As for the internal covering process, it takes a while.

When Hu Chengjun and the management saw the first batch of silicon nanobottles coming off the assembly line, they couldn't wait to order:

"Dr. He, take a look."

He Zhongli did not hesitate, and took 20 medicine bottles from them for careful testing by the laboratory. Shandong Pharmaceutical Glass mobilized all the inspectors to carefully test these 20 medicine bottles.

After more than three hours, the person in charge of the laboratory came out with a smile on his face: "Mr. Hu, good news. In the sampling results, all the data are in line with expectations."

Hu Chengjun, who was looking at the test report, couldn't help laughing: "In 2005, we negotiated with the German company SCHOTT and planned to purchase collectively and exchange quantity for price. But the other party's attitude was very arrogant and the price would not be reduced by a penny. You have to pay half a year in advance. From today on, things will change."

Anyone who witnessed the negotiations at that time will remember this incident in their hearts. It was an unforgettable shame.

After calming down, Hu Chengjun turned around and said, "Vice President Zhang."

"Mr. Hu, please give me your instructions." A tall, thin middle-aged man stood up.

"Immediately prepare information and samples and send them to Peking for testing. By the way, send a copy to our colleagues as well."

"Hahaha……"

The title of crusher in developed countries is not for nothing.

Now that Chinese companies have mastered the commanding heights of technology, they naturally don’t need to be too polite to foreign companies and can just get started.

An invisible chill spread from Lu Province Pharmaceutical Glass Company to all directions.

With the samples and test reports one after another, they reached Peiping, Deutsche Schott, American Corning, Dongying Electric Glass, and domestic peer companies.

In addition, as purchasers of medicinal glass products, various domestic pharmaceutical companies have obtained samples and test reports first.

Subsequently, the world's top ten pharmaceutical giants, Johnson \u0026 Johnson, Roche, Pfizer, Novartis, Bayer, Merck, GlaxoSmithKline, Sanofi Pasteur, Gileadco, Aspen Likang has also received samples and test reports one after another.

The new product of Shandong Pharmaceutical Glass is like a blockbuster, hitting the hearts of these companies.

If we talk about Peiping, I feel very happy.

Schott, Corning, and Electric Glass, the three companies that monopolize borosilicate glass all over the world, felt a chill.

As for the top ten pharmaceutical giants, their feelings are sour and complicated, but as capitalists, they are not too emotional. If Lu Province Pharmaceutical Glass really achieves large-scale mass production, it is not impossible to change suppliers. .

Stimulated by this news, the stock price of Shandong Pharmaceutical Glass entered a state of continuous daily limit.

On the contrary, the stock prices of foreign Schott, Corning, and Electrical Glass have all fallen to varying degrees. Many people who have received the wind in advance have begun to short these three companies.

Domestic Zhengchuan shares, etc., have not suffered a serious plunge, because the mid-to-high-end market targeted by Shandong Pharmaceutical Glass, and those who are mixed in the low-end market, have not yet had a significant impact.

However, Zhengchuan Holdings, Four Star Glass, and Kibin Group, which are prepared for danger in times of peace, have also become active.

They studied the announcements disclosed by Lu Province Pharmaceuticals and found that Suiren Company’s authorization terms did not include exclusive authorization provisions, which indicated that they might obtain the authorization from Suiren Company.